Prostate Cancer Test Developments To Improve Prediction Of Disease Course

Prostate cancer is a slow growing cancerous tumor. It puts forth symptoms at a fairly advanced stage. However if people undertake yearly medical checkups including prostate cancer tests, (which they are supposed to do after 40) the chances of early stage detection of the same are bright.

Researchers and Scientists of John Hopkins Oncology Center have proved that the measuring of the chemical process linked with genetic change initiated with the prostate cancer makes early stage detection of prostate cancer. Always detection of cancer at preliminary stage facilitates complete cure.

U.S and U.K scientists are developing a test for prostate cancer using a sample of prostate fluid taken through a needle inserted under local anesthetic and takes less than three minutes to complete. This will be a boon to the patients, health officials and Doctors. A Prasanna de Silva, chair of the organic chemistry at Queen’s University Belfast, U.K said that the new test was: ” A convenient and quick method which provides early warning of prostate cancer which will bring relief to many men”.

By far, the most popular prostate cancer test, Prostate Specific Antigen test (PSA) is conduced throughout the world. PSA is a protein secreted by prostate gland and abnormally higher values indicate the presence of cancer forming cells. The PSA test is helpful for a Physician in measuring the PSA level in the patient’s blood. In conjunction with DRE-digital rectum examination, this test empowers the physician to measure the size of the prostate gland.

Pharmaceuticals Scientists based at Maryland have identified a protein – HAAH enzyme might prove to be a biomarker, the sensitivity and specificity of which is much more accurate than the current methods for cancer detection. This biomarker test will detect cancer very fast and hence will be useful in preventing prostate cancer recurrence.

By means of another simple test called DNA test, which pinpoints risk genes, the Scientists of the Swedish Medical University Karolinsk Institutet hope to predict occurrence of prostate cancer by identifying the risk genes in patients. If the risk genes are 4 to 5 times in excess, the onset of prostate cancer is a certainty. Even in the cases of partial cure setting in, the risk of prostate cancer recurrence is possible.

Now let us turn our attention to nanoparticles prostate cancer test. Golden nanoparticles are primarily mixed in a solution. Nanoparticles are directed to attach themselves to cancer producing proteins. When the patient’s blood drops are mixed in the nanoparticles solution. they seek out the protein. As nanoparticles cluster around proteins, the inference is the presence of prostate cancer. If there is no clustering, there is no evidence of cancer.

Is being obese, an obstruction for an accurate Prostate cancer test? Texas University Health Science Center in San Antonio, came to the conclusion that in obese men, the sensitivity of PSA testing is being blunted. Doctors believe that obese men produce more estrogen, which drives down testosterone levels and could affect cells that produce antigen in the test.

Be sure to check out OnProstateCancer.com for comprehensive information on prostate cancer recurrence. To find all the advice and insights that you may need about prostate cancer test at your fingertips, Follow the links right now !